GSTM2 modulates size and number of LDs in HepG2 cells To further investigate the potential regulatory mechanism, we generated a GSTM2 -knockdown stable cell line (shGSTM2-HepG2) that expressed less GSTM2 mRNA and protein than control cells (shNC-HepG2) (Fig
Technique: Dispense the diluent slowly along the inner wall of the vial
Effective treatments, like GLP-1 drugs, are rarely risk-free
Lot tracking is standard in pharmaceutical management for a reason
The compound works primarily by activating an enzyme called AMP-activated protein kinase (AMPK), which influences glucose metabolism, lipid regulation, and cellular energy balance
[PubMed] [Google Scholar] 5.Wee L.E., Lim J.T., Tay A.T., Pang D., Dickens B., Chiew C.J., Ong B., Lye D.C.B., Tan K.B